When the atypical protein amyloid forms in bone marrow and in the body’s organs, it obstructs normal function, causing slow and sometimes fatal failure of the heart, kidneys, spleen, nervous system, or digestive tract. Research is slowly revealing that with no known cure and limited treatment, symptoms of amyloidosis are treatable with medical cannabis for various reasons.
Understanding the Effects of Amyloidosis
Amyloidosis doesn’t necessarily attack the same organs in every sufferer, and different types of amyloidosis impact different organs. The cause of the primary type of amyloidosis is unknown; secondary amyloidosis is caused by certain types of cancer; and familial amyloidosis is inherited in families. The most common type of amyloidosis is Alzhemier’s disease.
The symptoms of the disease are harsh and based on the type of amyloidosis, which varies. Heart-related symptoms include shortness of breath and irregular heartbeat; kidney-related signs include foamy urine and swelling in legs, stomach, arms, and lungs; nerve-related evidence includes numbness and carpal tunnel syndrome; and gastrointestinal-related symptoms include an enlarged tongue and unexplained weight loss.
Treatment for Amyloidosis is also harsh, including high-dose chemotherapy, steroids, and liver and kidney transplant.
The Potential for Medical Cannabis to Help With Amyloidosis
The Amyloidosis Foundation reports that the U.S. Office of Rare Diseases brands the condition extraordinary, affecting less than 200,000 of the country’s population. The foundation says the most significant setback in treating the disease is the lack of early diagnosis, which is all the more reason reports of medical cannabis calming the condition are hopeful.
While THC stunts the disease by preventing amyloid buildup, CBD may help alleviate symptoms of nausea, anxiety, and depression. One of the most notable characteristics of CBD that aids in treating symptoms of amyloidosis is the cannabinoid’s anti-inflammatory effects, which are especially helpful in gastrointestinal-related conditions that cause an enlarged tongue and swelling in other body parts and organs.
Different strains of medical cannabis reportedly assist in alleviating symptoms for different types of Amyloidosis. While indica-dominant strains help anxiety, pain, and lack of appetite, sativa-dominant strands ease nausea and fight fatigue.
Researchers theorize that cannabinoids have beneficial antioxidant properties, and THC suppresses cell-mediated immunity, which is significant to amyloidosis. A 2004 study on the role of the endocannabinoid system in Alzheimer’s disease (AD) suggests that cannabinoids that alleviate symptoms of amyloidosis do the same for dementia-related disorders. The researchers concluded that, “It can then be speculated that both CB1 and CB2 agonists as well as FAAH inhibitors could have beneficial effects on the prevention of the inflammatory process linked to Aβ deposition. Further studies will clarify this hypothesis, that open a new perspective for cannabinoid and AD research.”
A Journal of Alzheimer’s Disease study in 2016 pointed out that cannabinoid receptor two is linked to amyloid processing in a mice trial, suggesting that cannabis-based therapy may be the answer to dementia disease. While no definitive discoveries regarding medical cannabis and amyloidosis have been made, research thus far suggests that both THC and CBD will continue to be at the forefront of possible therapies as successful studies continue.
Whether you are new to cannabis and need to learn the basics, or are simply trying to achieve more positive cannabis experiences, Veriheal’s coaches are here to help. You have the opportunity to become informed about this wonderful plant. Book an appointment today with one of our compassionate coaches to have a private discussion about your cannabis journey.
We use our own as well as third party cookies to improve your site experience and the services we make available. You can learn more about our use of cookies in our Privacy Policy.
Content Disclamer
The statements made regarding cannabis products on this website have not been evaluated by the Food and Drug Administration (FDA). Cannabis is not an FDA-approved substance and is still illegal under federal law. The information provided on this website is intended for educational purposes only and is not intended to diagnose, treat, cure, or prevent any disease. It is not intended as medical advice and should not be considered as a substitute for advice from a healthcare professional. We strongly recommend that you consult with a physician or other qualified healthcare provider before using any cannabis products. The use of any information provided on this website is solely at your own risk.